Original Research
Published on 14 Jul 2022
Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
in Gastrointestinal and Hepatic Pharmacology
- 5,170 views
- 12 citations
Original Research
Published on 14 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 12 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 11 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 08 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 05 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 04 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Editorial
Published on 01 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 01 Jul 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 28 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 28 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 21 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 21 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Technology and Code
Published on 20 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 20 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 15 Jun 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 15 Jun 2022
in Gastrointestinal and Hepatic Pharmacology